New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
06:32 EDTPCRXPacira Pharmaceuticals announces FDA approval for Exparel manufacturing
Pacira Pharmaceuticals announced that the FDA approved an additional bulk manufacturing suite, referred to as Suite C, for Exparel. The suite is housed at the company’s Science Center Campus in San Diego, where Exparel is currently manufactured.
News For PCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2016
15:28 EDTPCRXFollow-up: Pacira upgraded to Buy on valuation at BofA/Merrill
Subscribe for More Information
15:13 EDTPCRXPacira upgraded to Buy from Neutral at BofA/Merrill
Subscribe for More Information
January 27, 2016
07:30 EDTPCRXPiper reiterates Overweight on Pacira after surgeon survey
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use